LekoskopLekoskop
EN All changes
Medicine recalls and shortages › Recalls and defects › 30 Jun 2025
Medicines recall

Omeprazole 20 mg/15 ml Oral Solution

Issued on 30 Jun 2025 · source: MHRA — Medicines and Healthcare products Regulatory Agency
Affected batches: 3230528 (30/09/2025)
Check the batch number on the pack. The medicine remains licensed; other batches are not affected.
Class 3 recall · DMRC-35139406 · PL: 25258/0383 · licence holder: Glenmark Pharmaceuticals Europe Ltd · active ingredient: Omeprazole · licence PL: 25258/0383

What this means

The MHRA has issued a medicines recall or defect notification. Class 1: risk to life, immediate recall. Class 2: may cause mistreatment or harm, recall within 48 hours. Class 3: unlikely to cause harm, recall within 5 days. Class 4 (defect notification): no recall, caution in use. The medicine remains licensed; only the listed batches are affected. Do not stop treatment without speaking to your doctor or pharmacist.

Class 3 recall · DMRC-35139406

ProductLicenceActive ingredientGTIN
Omeprazole 20 mg/15 ml Oral SolutionPL: 25258/0383Omeprazole

Batches (expiry): 3230528 (30/09/2025)

Background: Glenmark Pharmaceuticals Europe Ltd is recalling a specific batch of Omeprazole Oral Solution as a precautionary measure due to an investigation following a customer complaint indicating precipitation and discoloration of the product in the bottles. A root cause has identified that this is a result of an inadequate assembly of the plunger stem and the cup which could lead to a premature mixing of the two components of the medicinal product Advice for Healthcare Professionals: Stop supplying the above batch immediately. Quarantine all remaining stock and return it to your supplier using your supplier’s approved process.

Tracked from information published by the MHRA and the NHSBSA. This information is for guidance only and does not replace advice from your doctor or pharmacist.